WED, OCTOBER 28, 2026
Independent · In‑Depth · Practitioner‑Tested
General

China's AI Models vs China's AI Stocks: Diverging

Kimi K3.1 Pro sits fourth on the Intelligence Index the same week Chinese AI shares fall sharply.

🕐 6 min read 👁 25 views 📅 Oct 28, 2026

Two things are true in the same week. Chinese AI shares have fallen sharply as investors reassess demand, valuations and export restrictions. And Chinese models are at their strongest measured position yet.

The capability pictureThe equity picture
This weekKimi K3.1 Pro 4th on the Intelligence Index at 55Shares falling sharply, per Reuters
Distribution41% of Hugging Face downloads to March 2026Investors reassessing demand
Gap to frontierNarrowed from 12 points to 3Valuations being marked down
What is nextKimi open weights promised by 4 NovemberExport restrictions still tightening

Why both can be true

Releasing open weights does not require public-market funding, and it does not generate revenue either. A lab can ship a model that lands fourth on an independent index and change nothing about the earnings of any listed company. The index measures capability; the share price measures expected cash flows, and those have never been the same thing.

Export restrictions push the same way. Constraints on hardware hurt the companies that sell and deploy at scale more than they hurt a research team publishing weights, so the listed vehicles absorb the policy risk while the model output keeps improving.

What to watch instead of the share price

Whether Kimi K3.1 Pro's weights actually land on 4 November, and what the open-to-closed gap measures after they do. Artificial Analysis currently puts it at three points, down from twelve - roughly the difference between reasoning-effort settings on a single closed model. If that holds with weights in public hands, it changes what anyone needs to pay for, regardless of what the equities do.

Sources

Market reporting via The Neuron, 27 October, 27 October 2026. Index positions from the Artificial Analysis Intelligence Index.

⚖ Our Verdict

Open-weight releases do not need public-market funding, which is why the two can diverge this far.